Overview
National CineMedia (NCM) is America's Movie Network. As the largest cinema advertising network in the U.S., they unite brands with the power of movies and engage movie fans anytime and anywhere. NCM's Noovie pre-show is presented exclusively in 53 leading national and regional theater circuits including AMC Entertainment Inc. NCM's cinema advertising network offers broad reach and unparalleled audience engagement with over 20,400 screens in over 1,650 theaters in 190 Designated Market Areas® (all of the top 50). NCM Digital goes beyond the big screen, extending in-theater campaigns into online and mobile marketing programs to reach entertainment audiences. National CineMedia, Inc. owns a 48.0% interest in, and is the managing member of, National CineMedia, LLC.
Basic Stats
The share price of National CineMedia, Inc. as of September 5, 2025 is $4.39 / share. This is a decrease of 0.00% from the prior week. The market cap (or net worth) of National CineMedia, Inc. as of September 5, 2025 is $410.13 MM.
The Factor Analysis chart (below right) shows a view of National CineMedia, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 410.13 MM |
| EV | 372.93 MM |
| Shares Out. | 93.42 MM |
| Earnings Date | |
| EPS (TTM) | -0.22 |
| Dividend Yield | 2.73 % |
| Ex-Dividend Date | 2025-08-15 |
| Borrow Rate | 0.45 |
| Short Shares Avail. | 0.35 MM |
| Short Interest | 7.91 MM |
| Short Float | 8.54 % |
| Days to Cover | 17.48 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -36.10 % |
| Volatility (1 yr) | 0.45 |
| Beta | 0.39 |
| Sharpe Ratio (1 yr) | -0.89 |
| Sortino Ratio (1 yr) | -1.31 |
| PE Ratio | -20.20 |
| Price/Book | 1.17 |
| Price/TBV | 14.65 |
| Book/Market | 0.85 |
| EBIT/EV | -0.05 |
| EBIT(3yr avg)/EV | 0.56 |
| ROA | -0.04 |
| ROE | -0.05 |
| ROIC | -0.06 |
| CROIC | -0.05 |
| OCROIC | 0.08 |
| Implied Volatility | 100.82 % |
| Put/Call OI Ratio | 0.04 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for National CineMedia, Inc. is $6.94. The forecasts range from a low of $5.56 to a high of $7.88. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for National CineMedia, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-10-03 | Benchmark | Buy | Hold | Downgrade |
| 2022-09-26 | B. Riley Securities | Neutral | Maintains | |
| 2022-06-21 | B. Riley Securities | Neutral | Maintains | |
| 2022-04-13 | B. Riley Securities | Buy | Maintains | |
| 2021-11-04 | Wedbush | Neutral | Outperform | Upgrade |
| 2021-04-07 | Benchmark | Hold | Buy | Upgrade |
| 2020-10-09 | MKM Partners | Neutral | Maintains | |
| 2020-09-04 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2020-07-29 | Wedbush | Outperform | Neutral | Downgrade |
| 2020-05-06 | B. Riley FBR | Buy | Maintains | |
| 2020-05-04 | Wedbush | Outperform | Maintains | |
| 2020-04-09 | MKM Partners | Neutral | Maintains | |
| 2020-03-18 | Benchmark | Buy | Hold | Downgrade |
| 2020-03-18 | B. Riley FBR | Buy | Maintains | |
| 2020-03-02 | B. Riley | Neutral | Buy | Upgrade |
| 2020-02-21 | Wedbush | Outperform | Maintains | |
| 2020-02-21 | B. Riley FBR | Neutral | Maintains | |
| 2019-11-07 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2019-11-05 | B. Riley | Buy | Neutral | Downgrade |
| 2019-09-18 | Benchmark | Buy | Maintains | |
| 2018-09-24 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-08-07 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-06-25 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-05-08 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-03-19 | B. Riley FBR | Neutral | Buy | Upgrade |
| 2017-11-07 | B. Riley FBR | Buy | Neutral | Downgrade |
| 2017-09-28 | Credit Suisse | Neutral | Maintains | |
| 2017-08-02 | Wedbush | Neutral | Initiate | |
| 2017-05-05 | JP Morgan | Overweight | Neutral | Downgrade |
| 2017-05-05 | FBR Capital | Outperform | Market Perform | Downgrade |
| 2017-03-15 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2017-02-01 | Credit Suisse | Outperform | Underperform | Downgrade |
| 2016-07-20 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2015-05-12 | Stifel Nicolaus | Buy | Maintains | |
| 2015-05-12 | FBR Capital | Market Perform | Outperform | Upgrade |
| 2015-05-07 | JP Morgan | Overweight | Initiate | |
| 2014-11-04 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2014-11-04 | MKM Partners | Buy | Neutral | Downgrade |
| 2014-11-03 | FBR Capital | Outperform | Market Perform | Downgrade |
| 2014-08-06 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2014-05-01 | B. Riley FBR | Neutral | Buy | Upgrade |
| 2014-04-01 | JP Morgan | Overweight | Upgrade | |
| 2014-02-25 | Benchmark | Buy | Upgrade | |
| 2014-02-21 | B. Riley FBR | Buy | Neutral | Downgrade |
| 2013-11-05 | FBR Capital | Market Perform | Initiate | |
| 2013-11-05 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2013-10-23 | JP Morgan | Overweight | Neutral | Downgrade |
| 2013-09-11 | Benchmark | Hold | Initiate | |
| 2013-06-24 | Janco Partners | Strong Buy | Initiate | |
| 2013-05-03 | JP Morgan | Neutral | Overweight | Upgrade |
| 2013-02-22 | Barrington Research | Outperform | Market Perform | Downgrade |
| 2012-11-19 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2012-11-16 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2012-10-23 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2012-09-06 | Credit Suisse | Outperform | Initiate | |
| 2012-05-08 | Imperial Capital | In-Line | Downgrade | |
| 2012-04-18 | Barrington Research | Market Perform | Initiate | |
| 2012-03-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2012-02-24 | Wedbush | Neutral | Maintains | |
| 2012-02-15 | PiperJaffray | Overweight | Upgrade | |
| 2023-04-12 | Wedbush | Outperform | Reiterate | |
| 2023-04-19 | Wedbush | Outperform | Maintains | |
| 2023-11-08 | Wedbush | Neutral | Neutral | Maintains |
| 2023-08-03 | Wedbush | Outperform | Neutral | Downgrade |
| 2023-08-25 | Benchmark | Speculative Buy | Speculative Buy | Maintains |
| 2024-03-19 | B. Riley Securities | Neutral | Buy | Upgrade |
| 2023-08-16 | Benchmark | Hold | Speculative Buy | Upgrade |
| 2023-09-22 | Benchmark | Speculative Buy | Speculative Buy | Maintains |
| 2024-03-20 | Benchmark | Speculative Buy | Speculative Buy | Reiterate |
| 2024-03-19 | Wedbush | Neutral | Neutral | Maintains |
| 2024-03-12 | Wedbush | Neutral | Neutral | Reiterate |
| 2024-05-07 | Benchmark | Speculative Buy | Speculative Buy | Reiterate |
| 2024-06-17 | Benchmark | Speculative Buy | Speculative Buy | Reiterate |
| 2024-08-06 | Benchmark | Speculative Buy | Speculative Buy | Reiterate |
| 2025-03-14 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-08-15 | Benchmark | Speculative Buy | Buy | Upgrade |
| 2024-08-06 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2024-08-16 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-11-06 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-03-07 | Benchmark | Buy | Buy | Reiterate |
| 2025-03-07 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-09-23 | Benchmark | Buy | Buy | Reiterate |
| 2025-03-14 | Wedbush | Neutral | Outperform | Upgrade |
| 2025-06-25 | Benchmark | Buy | Buy | Maintains |
| 2025-08-04 | Wedbush | Outperform | Outperform | Maintains |
